Atossa Therapeutics
ATOS
#10043
Rank
A$58.48 M
Marketcap
A$6.79
Share price
2.00%
Change (1 day)
364.79%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -A$46.92 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$35.79 Million, an increase over its 2023 earnings that were of -A$42.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$46.92 Million31.11%
2024 -A$35.79 Million-15.25%
2023 -A$42.23 Million11.62%
2022 -A$37.84 Million30.84%
2021 -A$28.92 Million15.58%
2020 -A$25.02 Million3.41%
2019 -A$24.2 Million51.16%
2018 -A$16.01 Million40.41%
2017 -A$11.4 Million27.54%
2016 -A$8.94 Million-47.49%
2015 -A$17.02 Million-17.25%
2014 -A$20.57 Million35.91%
2013 -A$15.14 Million112.3%
2012 -A$7.13 Million46.53%
2011 -A$4.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.45 B-86,180.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$1.93 B-4,659.31%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$1.92 B-4,656.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
A$58.48 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-A$0.14 Billion 229.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-A$11.01 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA